Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EG NordLab AB
AB
Active
Org 5592468150
Sjöängsvägen 7, 192 72
Sollentuna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2020
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
EG NordLab AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
192
Staff expenses
—
−0
—
—
—
EBITDA
−8
1
—
—
92
Depreciation & amort.
−0
—
−0
−0
−0
EBIT
−8
1
0
0
92
Net financials
—
0
—
—
—
Profit before tax
−8
1
0
0
92
Tax
−0
—
−0
−0
−0
Net profit
−8
1
0
0
92
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
17
46
38
38
442
Equity
17
18
38
38
111
Long-term debt
0
—
0
0
0
Short-term debt
0
28
0
0
331
Total debt
—
28
—
—
331
Financial ratios
5-year trend
EBITDA margin
47.9%
This company
15.8%
Market median
+203% vs market
2020
2024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
2020
2024
Return on equity
82.9%
This company
18.4%
Market median
+351% vs market
2020
2024
Net profit margin
47.9%
This company
8.1%
Market median
+491% vs market
2020
2024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
2020
2024
Debt / equity
2.98×
This company
0.62×
Market median
-381% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
View
PDF
More on EG NordLab AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
